EFFICACY AND SAFETY OF DUPILUMAB TREATMENT UP TO 1 YEAR IN INFANTS AND PRESCHOOL CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

被引:0
|
作者
Cork, Michael J. [1 ,2 ]
Paller, Amy S. [3 ,4 ]
Siegfried, Elaine C. [1 ,2 ,5 ,6 ]
Xiao, Jing [7 ]
Prescilla, Randy [8 ]
Dubost-Brama, Ariane [9 ]
Bansal, Ashish [7 ]
机构
[1] Univ Sheffield, Sheffield Dermatol Res, Sheffield, S Yorkshire, England
[2] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[4] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[5] St Louis Univ, St Louis, MO USA
[6] Cardinal Glennon Childrens Hosp, St Louis, MO USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Cambridge, MA USA
[9] Sanofi, Chilly Mazarin, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P10.8
引用
收藏
页码:53 / 53
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
    Zhang, Jianzhong
    Zhao, Yan
    Zhou, Qinghong
    Xu, Yuyu
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55
  • [22] Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
    Dupuis, Josephine
    Tauber, Marie
    Mahe, Emmanuel
    Jachiet, Marie
    Soria, Angele
    Tetart, Florence
    Puzenat, Eve
    Pasteur, Justine
    Raison-Peyron, Nadia
    Giordano-Labadie, Francoise
    Droitcourt, Catherine
    Leleu, Camille
    Nosbaum, Audrey
    Aubert, Helene
    Moigne, Marie L. E.
    Bernier, Claire
    Barbarot, Sebastien
    Ezzedine, Khaled
    Diaz, Emmanuelle
    Hubiche, Thomas
    Faiz, Sarah
    Azib, Selma
    Dezoteux, Frederic
    Chosidow, Olivier
    Staumont-Salle, Delphine
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e174 - e178
  • [23] Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials
    Wu, Shuying
    Wang, Huiping
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (03): : 601 - 610
  • [24] Rapid response to dupilumab treatment in children with moderate-to-severe atopic dermatitis: A case series
    Votto, Martina
    Delle Cave, Francesco
    De Filippo, Maria
    Marseglia, Alessia
    Marseglia, Gian Luigi
    Brazzelli, Valeria
    Licari, Amelia
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 31 - 33
  • [25] Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
    Agache, Ioana
    Song, Yang
    Posso, Margarita
    Alonso-Coello, Pablo
    Rocha, Claudio
    Sola, Ivan
    Beltran, Jessica
    Akdis, Cezmi
    Akdis, Mubeccel
    Brockow, Knut
    Chivato, Tomas
    del Giacco, Stefano
    Eiwegger, Thomas
    Eyerich, Kilian
    Gimenez-Arnau, Ana
    Gutermuth, Jan
    Guttman-Yassky, Emma
    Maurer, Marcus
    Ogg, Graham
    Ong, Peck Y.
    O'Mahony, Liam
    Schwarze, Jurgen
    Werfel, Thomas
    Canelo-Aybar, Carlos
    Palomares, Oscar
    Jutel, Marek
    ALLERGY, 2021, 76 (01) : 45 - 58
  • [26] Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
    Andrew Blauvelt
    Marjolein de Bruin-Weller
    Eric L. Simpson
    Zhen Chen
    Marius Ardeleanu
    Ana B. Rossi
    Dermatology and Therapy, 2022, 12 : 9 - 13
  • [27] Efficacy of dupilumab in moderate and severe atopic dermatitis
    Weidinger, Stephan
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Schmitt, Jochen
    Leshem, Yael A.
    Katoh, Norito
    Chen, Zhen
    Zhang, Haixin
    Shumel, Brad
    Bansal, Ashish
    Chao, Jingdong
    Lu, Yufang
    Rossi, Ana B.
    Abramova, Alvina
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 247 - 260
  • [28] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Andreas Kuznik
    Gaëlle Bégo-Le-Bagousse
    Laurent Eckert
    Abhijit Gadkari
    Eric Simpson
    Christopher N. Graham
    LaStella Miles
    Vera Mastey
    Puneet Mahajan
    Sean D. Sullivan
    Dermatology and Therapy, 2017, 7 : 493 - 505
  • [29] Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van der Schaft, J.
    Bakker, D.
    Ariens, L.
    Thijs, J. H.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 82 - 82
  • [30] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Kuznik, Andreas
    Bego-Le-Bagousse, Gaelle
    Eckert, Laurent
    Gadkari, Abhijit
    Simpson, Eric
    Graham, Christopher N.
    Miles, LaStella
    Mastey, Vera
    Mahajan, Puneet
    Sullivan, Sean D.
    DERMATOLOGY AND THERAPY, 2017, 7 (04) : 493 - 505